malaria vaccines

Preferred Label : malaria vaccines;

MeSH definition : Vaccines made from antigens arising from any of the four strains of Plasmodium which cause malaria in humans, or from P. berghei which causes malaria in rodents.;

MeSH synonym : malarial vaccines; vaccines, malaria; vaccines, malarial; Malaria Vaccine; Vaccine, Malaria; Malarial Vaccine; Vaccine, Malarial;

MeSH annotation : coord IM with specific Plasmodium /immunol (IM);

Wikipedia link : https://en.wikipedia.org/wiki/Malaria vaccines;

Is substance : O;

Details

Origin ID

D017780;

UMLS CUI

C0206255;

Allowable qualifiers
- administration and dosage [MeSH Qualifier]
- adverse effects [MeSH Qualifier]
- agonists [MeSH Qualifier]
- analysis [MeSH Qualifier]
- antagonists and inhibitors [MeSH Qualifier]
- biosynthesis [MeSH Qualifier]
- blood [MeSH Qualifier]
- cerebrospinal fluid [MeSH Qualifier]
- chemical synthesis [MeSH Qualifier]
- chemistry [MeSH Qualifier]
- classification [MeSH Qualifier]
- contraindications [MeSH Qualifier]
- economics [MeSH Qualifier]
- genetics [MeSH Qualifier]
- history [MeSH Qualifier]
- immunology [MeSH Qualifier]
- isolation and purification [MeSH Qualifier]
- metabolism [MeSH Qualifier]
- pharmacokinetics [MeSH Qualifier]
- pharmacology [MeSH Qualifier]
- poisoning [MeSH Qualifier]
- radiation effects [MeSH Qualifier]
- standards [MeSH Qualifier]
- supply and distribution [MeSH Qualifier]
- therapeutic use [MeSH Qualifier]
- toxicity [MeSH Qualifier]
- urine [MeSH Qualifier]
Automatic exact mappings (from CISMeF team)
- Algid malaria (disorder) [SNOMED CT concept]
- Ovale malaria (disorder) [SNOMED CT concept]
Indexing information
- MSP3 protein, plasmodium falciparum (181-276) [MeSH Supplementary Concept]
- SPf66 protein, plasmodium [MeSH Supplementary Concept]
- transmission-Blocking vaccine based on Pfs25 [MeSH Supplementary Concept]
Record concept(s)
- malaria vaccines [MeSH concept]
Related MeSH Supplementary Concept(s)
- (T1BT)4-P3C polyoxime vaccine [MeSH Supplementary Concept]
- ChAd63 Pfs25-IMX313 malaria vaccine [MeSH Supplementary Concept]
- GMZ2 vaccine [MeSH Supplementary Concept]
- MSP1(42)-3D7 alhydrogel vaccine [MeSH Supplementary Concept]
- MSP1(42)-FVO alhydrogel vaccine [MeSH Supplementary Concept]
- MVA Pfs25-IMX313 malaria vaccine [MeSH Supplementary Concept]
- PADRE 45 [MeSH Supplementary Concept]
- PfCP2.9 vaccine [MeSH Supplementary Concept]
- PfCSP DNA vaccine [MeSH Supplementary Concept]
- Pvs25 protein, P vivax [MeSH Supplementary Concept]
- Pvs28 protein, P vivax [MeSH Supplementary Concept]
- R 32NS1(81) [MeSH Supplementary Concept]
- RTS malaria vaccine [MeSH Supplementary Concept]
- RTS,S-AS01 vaccine [MeSH Supplementary Concept]
- RTS,S-AS01B vaccine [MeSH Supplementary Concept]
- RTS,S-AS01E vaccine [MeSH Supplementary Concept]
- RTS,S-AS02A vaccine [MeSH Supplementary Concept]
- RTS,S-AS02D vaccine [MeSH Supplementary Concept]
See also (suggested by CISMeF)
- malaria [MeSH Descriptor]
Semantic type(s)
- Immunologic Factor [UMLS semantic type]
- Pharmacologic Substance [UMLS semantic type]
UMLS correspondences (same concept)
- malaria vaccines [ATC Code]
Validated automatic mappings to BTNT
- malaria vaccines [ATC Code]

Keyword's position in hierarchy(ies) :

Main resources

You can consult :

recommendations
documents concerning education
documents for patients